Detailed price information for Mind Medicine Mindmed Inc (MNMD-Q) from The Globe and Mail including charting and trades.

Munch was one of the first truly modern painters. One who dug beneath the social and psychological veneer of the everyday.

Normalisation of excessive alcohol consumption, and drug abuse weakens individuals, dismantles families, and disrupts social ...

Its product candidates in clinical development include valbenazine to treat dyskinetic cerebral palsy and schizophrenia; NBI-1076986 to treat movement disorders; Osavampator for inadequate ...

The company offers CAPLYTA for the treatment of schizophrenia and bipolar depression in adults. It is also involved in developing lumateperone, which is in Phase 3 clinical trial for the treatment ...

Feb. 26, 2025 — The symptoms of schizophrenia vary greatly from person to person. A new study shows how these differences manifest themselves in the structure of the ... Genetic Risk of ...

We are witnessing a broader cognitive and emotional crisis, marked by declining attention spans, increased impulsivity, and ...

Both bipolar disorder and schizophrenia can cause hallucinations and delusions, but symptoms are more severe in schizophrenia. Bipolar disorder involves shifts in energy and mood. Bipolar disorder ...

HLS also forecast relatively sales in Canada this year for schizophrenia treatment Clozaril of between C$35.5 million and C$36 million,. Sales for the U.S. Clozaril business are expected to be ...

Bristol-Myers Squibb's $14 billion bet on buying Karuna Therapeutics looks set to pay off after it got FDA approval for the schizophrenia drug at the heart of the deal. The US regulator has ...

Van Lanschot Kempen Life Sciences Conference MADRID, Spain and CAMBRIDGE, Mass., March 14, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage ...